Thursday, May 2, 2024

Enlaza Therapeutics Finds $100M

La Jolla-based Enlaza Therapeutics, which is working on protein drugs, says it has raised $100M in a Series A financing round. The funding was led by Life Sciences Group of J.P. Morgan Private Capital, and also included existing investors Frazier Life Sciences, Avalon Ventures, Lightspeed Venture Partners, and Samsara BioCapital along with new investorsAmgen Ventures, Regeneron Ventures, Bregua Corporation, Pappas Capital, and Alexandria Venture Investments.